Integrated surgical systems report

Citation

(1998), "Integrated surgical systems report", Industrial Robot, Vol. 25 No. 3. https://doi.org/10.1108/ir.1998.04925cab.008

Integrated surgical systems report

Integrated surgical systems report

Keywords Acquisition, Medical, Robots

Integrated Surgical Systems, Inc. (ISS), developer of computer-controlled robotic products for surgical applications, has announced the acquisition of Innovative Medical Machines International, SA (IMMI) of Lyon, France, a developer of surgical applications of robotics technology for use in neurosurgeries. To date, the company has installed seven NeuroMate Systems, a surgical robotic product used to precisely locate brain structures, in France and Japan, supporting neurosurgeries on more than 1,500 patients. "IMMI's expertise in robotic technologies for neurosurgery complements our technology extremely well, " said Dr Ramesh Trivedi, president and chief executive officer of ISS. "Acquiring IMMI expands our product line, allowing us to enter the $760 million neurosurgery market. As NeuroMate has already received approval in Japan, Europe and the US, the acquisition broadens our geographic reach as well."

During the third quarter of 1997, the company sold two ROBODOC(R) systems; its leading computer controlled robotic product used to perform precise total hip replacement. The sale of ROBODOC to the Barmbek clinic in Hamburg, Germany will provide benefits, such as greater surgical accuracy and less trauma, to their patients. "The continuing strong sales momentum throughout the quarter and interest from leading orthopaedic companies clearly validates our technology," stated Dr Trivedi. "In September, we signed a software development contract with DePuy, Inc., our fourth with a manufacturer of hip prostheses. This contract represents a commitment by another major orthopaedic company to further advance its business relationship with ISS in order to meet its customers' demand for the ROBODOC and NeuroMate systems and facilitates a broader adoption of our technology." The ROBODOC surgical assistant system (ROBODOC) has been used to perform precise total hip replacement surgical procedures on more than 1,500 patients world-wide. ROBODOC is currently being marketed in Europe, and ISS is expected to file for FDA approval in the US this year. NeuroMate, ISS's neurosurgery product, is the first robotic technology for use in stereotactic neurosurgeries. ISS has installed seven NeuroMate systems in France and Japan, which have supported neurosurgery on more than 1,500 patients to date.

(Source: BRA)